Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2004-06, Vol.10 (6), p.649-649
Hauptverfasser:	Willett, Christopher G, Boucher, Yves, di Tomaso, Emmanuelle, Duda, Dan G, Munn, Lance L, Tong, Ricky T, Chung, Daniel C, Sahani, Dushyant V, Kalva, Sanjeeva P, Kozin, Sergey V, Mino, Mari, Cohen, Kenneth S, Scadden, David T, Hartford, Alan C, Fischman, Alan J, Clark, Jeffrey W, Ryan, David P, Zhu, Andrew X, Blaszkowsky, Lawrence S, Chen, Helen X, Shellito, Paul C, Lauwers, Gregory Y, Jain, Rakesh K
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Cancer Research corrigendum Erratum Infectious Diseases Metabolic Diseases Molecular Medicine Neurosciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	649
container_issue	6
container_start_page	649
container_title	Nature medicine
container_volume	10
creator	Willett, Christopher G Boucher, Yves di Tomaso, Emmanuelle Duda, Dan G Munn, Lance L Tong, Ricky T Chung, Daniel C Sahani, Dushyant V Kalva, Sanjeeva P Kozin, Sergey V Mino, Mari Cohen, Kenneth S Scadden, David T Hartford, Alan C Fischman, Alan J Clark, Jeffrey W Ryan, David P Zhu, Andrew X Blaszkowsky, Lawrence S Chen, Helen X Shellito, Paul C Lauwers, Gregory Y Jain, Rakesh K
description
doi_str_mv	10.1038/nm0604-649c
format	Article
fullrecord	<record><control><sourceid>springer</sourceid><recordid>TN_cdi_springer_journals_10_1038_nm0604_649c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_nm0604_649c</sourcerecordid><originalsourceid>FETCH-springer_journals_10_1038_nm0604_649c3</originalsourceid><addsrcrecordid>eNqVj01OwzAQhS0EEuVnxQXmAATGyk-TbktLD4AQO8txJs1UiYPsJBKsOTg2cAE2M0_znt7oE-JO4oPEtHy0AxaYJUVWmTOxknlWJHKNb-dB47pMyiovLsWV9ydETDGvVuJrOzpHZuLRbiBqPpJt5mEDTxzvQAs3ZA3B1OkpDILX3fM-8e9kuGUD2k5cj80H1LRow5_zoGvotP8xFu3N3GsH1LahzANb6ELCQuzWPRgdqt2NuGh17-n2b1-L-_3uZXsIXxzbIzl1Gmdng6UkqkiqfklVJE3_Gf8GNTNd7g</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Willett, Christopher G ; Boucher, Yves ; di Tomaso, Emmanuelle ; Duda, Dan G ; Munn, Lance L ; Tong, Ricky T ; Chung, Daniel C ; Sahani, Dushyant V ; Kalva, Sanjeeva P ; Kozin, Sergey V ; Mino, Mari ; Cohen, Kenneth S ; Scadden, David T ; Hartford, Alan C ; Fischman, Alan J ; Clark, Jeffrey W ; Ryan, David P ; Zhu, Andrew X ; Blaszkowsky, Lawrence S ; Chen, Helen X ; Shellito, Paul C ; Lauwers, Gregory Y ; Jain, Rakesh K</creator><creatorcontrib>Willett, Christopher G ; Boucher, Yves ; di Tomaso, Emmanuelle ; Duda, Dan G ; Munn, Lance L ; Tong, Ricky T ; Chung, Daniel C ; Sahani, Dushyant V ; Kalva, Sanjeeva P ; Kozin, Sergey V ; Mino, Mari ; Cohen, Kenneth S ; Scadden, David T ; Hartford, Alan C ; Fischman, Alan J ; Clark, Jeffrey W ; Ryan, David P ; Zhu, Andrew X ; Blaszkowsky, Lawrence S ; Chen, Helen X ; Shellito, Paul C ; Lauwers, Gregory Y ; Jain, Rakesh K</creatorcontrib><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/nm0604-649c</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; corrigendum ; Erratum ; Infectious Diseases ; Metabolic Diseases ; Molecular Medicine ; Neurosciences</subject><ispartof>Nature medicine, 2004-06, Vol.10 (6), p.649-649</ispartof><rights>Springer Nature America, Inc. 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Willett, Christopher G</creatorcontrib><creatorcontrib>Boucher, Yves</creatorcontrib><creatorcontrib>di Tomaso, Emmanuelle</creatorcontrib><creatorcontrib>Duda, Dan G</creatorcontrib><creatorcontrib>Munn, Lance L</creatorcontrib><creatorcontrib>Tong, Ricky T</creatorcontrib><creatorcontrib>Chung, Daniel C</creatorcontrib><creatorcontrib>Sahani, Dushyant V</creatorcontrib><creatorcontrib>Kalva, Sanjeeva P</creatorcontrib><creatorcontrib>Kozin, Sergey V</creatorcontrib><creatorcontrib>Mino, Mari</creatorcontrib><creatorcontrib>Cohen, Kenneth S</creatorcontrib><creatorcontrib>Scadden, David T</creatorcontrib><creatorcontrib>Hartford, Alan C</creatorcontrib><creatorcontrib>Fischman, Alan J</creatorcontrib><creatorcontrib>Clark, Jeffrey W</creatorcontrib><creatorcontrib>Ryan, David P</creatorcontrib><creatorcontrib>Zhu, Andrew X</creatorcontrib><creatorcontrib>Blaszkowsky, Lawrence S</creatorcontrib><creatorcontrib>Chen, Helen X</creatorcontrib><creatorcontrib>Shellito, Paul C</creatorcontrib><creatorcontrib>Lauwers, Gregory Y</creatorcontrib><creatorcontrib>Jain, Rakesh K</creatorcontrib><title>Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>corrigendum</subject><subject>Erratum</subject><subject>Infectious Diseases</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVj01OwzAQhS0EEuVnxQXmAATGyk-TbktLD4AQO8txJs1UiYPsJBKsOTg2cAE2M0_znt7oE-JO4oPEtHy0AxaYJUVWmTOxknlWJHKNb-dB47pMyiovLsWV9ydETDGvVuJrOzpHZuLRbiBqPpJt5mEDTxzvQAs3ZA3B1OkpDILX3fM-8e9kuGUD2k5cj80H1LRow5_zoGvotP8xFu3N3GsH1LahzANb6ELCQuzWPRgdqt2NuGh17-n2b1-L-_3uZXsIXxzbIzl1Gmdng6UkqkiqfklVJE3_Gf8GNTNd7g</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Willett, Christopher G</creator><creator>Boucher, Yves</creator><creator>di Tomaso, Emmanuelle</creator><creator>Duda, Dan G</creator><creator>Munn, Lance L</creator><creator>Tong, Ricky T</creator><creator>Chung, Daniel C</creator><creator>Sahani, Dushyant V</creator><creator>Kalva, Sanjeeva P</creator><creator>Kozin, Sergey V</creator><creator>Mino, Mari</creator><creator>Cohen, Kenneth S</creator><creator>Scadden, David T</creator><creator>Hartford, Alan C</creator><creator>Fischman, Alan J</creator><creator>Clark, Jeffrey W</creator><creator>Ryan, David P</creator><creator>Zhu, Andrew X</creator><creator>Blaszkowsky, Lawrence S</creator><creator>Chen, Helen X</creator><creator>Shellito, Paul C</creator><creator>Lauwers, Gregory Y</creator><creator>Jain, Rakesh K</creator><general>Nature Publishing Group US</general><scope/></search><sort><creationdate>20040601</creationdate><title>Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer</title><author>Willett, Christopher G ; Boucher, Yves ; di Tomaso, Emmanuelle ; Duda, Dan G ; Munn, Lance L ; Tong, Ricky T ; Chung, Daniel C ; Sahani, Dushyant V ; Kalva, Sanjeeva P ; Kozin, Sergey V ; Mino, Mari ; Cohen, Kenneth S ; Scadden, David T ; Hartford, Alan C ; Fischman, Alan J ; Clark, Jeffrey W ; Ryan, David P ; Zhu, Andrew X ; Blaszkowsky, Lawrence S ; Chen, Helen X ; Shellito, Paul C ; Lauwers, Gregory Y ; Jain, Rakesh K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-springer_journals_10_1038_nm0604_649c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>corrigendum</topic><topic>Erratum</topic><topic>Infectious Diseases</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Willett, Christopher G</creatorcontrib><creatorcontrib>Boucher, Yves</creatorcontrib><creatorcontrib>di Tomaso, Emmanuelle</creatorcontrib><creatorcontrib>Duda, Dan G</creatorcontrib><creatorcontrib>Munn, Lance L</creatorcontrib><creatorcontrib>Tong, Ricky T</creatorcontrib><creatorcontrib>Chung, Daniel C</creatorcontrib><creatorcontrib>Sahani, Dushyant V</creatorcontrib><creatorcontrib>Kalva, Sanjeeva P</creatorcontrib><creatorcontrib>Kozin, Sergey V</creatorcontrib><creatorcontrib>Mino, Mari</creatorcontrib><creatorcontrib>Cohen, Kenneth S</creatorcontrib><creatorcontrib>Scadden, David T</creatorcontrib><creatorcontrib>Hartford, Alan C</creatorcontrib><creatorcontrib>Fischman, Alan J</creatorcontrib><creatorcontrib>Clark, Jeffrey W</creatorcontrib><creatorcontrib>Ryan, David P</creatorcontrib><creatorcontrib>Zhu, Andrew X</creatorcontrib><creatorcontrib>Blaszkowsky, Lawrence S</creatorcontrib><creatorcontrib>Chen, Helen X</creatorcontrib><creatorcontrib>Shellito, Paul C</creatorcontrib><creatorcontrib>Lauwers, Gregory Y</creatorcontrib><creatorcontrib>Jain, Rakesh K</creatorcontrib><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Willett, Christopher G</au><au>Boucher, Yves</au><au>di Tomaso, Emmanuelle</au><au>Duda, Dan G</au><au>Munn, Lance L</au><au>Tong, Ricky T</au><au>Chung, Daniel C</au><au>Sahani, Dushyant V</au><au>Kalva, Sanjeeva P</au><au>Kozin, Sergey V</au><au>Mino, Mari</au><au>Cohen, Kenneth S</au><au>Scadden, David T</au><au>Hartford, Alan C</au><au>Fischman, Alan J</au><au>Clark, Jeffrey W</au><au>Ryan, David P</au><au>Zhu, Andrew X</au><au>Blaszkowsky, Lawrence S</au><au>Chen, Helen X</au><au>Shellito, Paul C</au><au>Lauwers, Gregory Y</au><au>Jain, Rakesh K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><date>2004-06-01</date><risdate>2004</risdate><volume>10</volume><issue>6</issue><spage>649</spage><epage>649</epage><pages>649-649</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><cop>New York</cop><pub>Nature Publishing Group US</pub><doi>10.1038/nm0604-649c</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 1078-8956
ispartof	Nature medicine, 2004-06, Vol.10 (6), p.649-649
issn	1078-8956 1546-170X
language	eng
recordid	cdi_springer_journals_10_1038_nm0604_649c
source	Nature; Alma/SFX Local Collection
subjects	Biomedical and Life Sciences Biomedicine Cancer Research corrigendum Erratum Infectious Diseases Metabolic Diseases Molecular Medicine Neurosciences
title	Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A50%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-springer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Corrigendum:%20Direct%20evidence%20that%20the%20VEGF-specific%20antibody%20bevacizumab%20has%20antivascular%20effects%20in%20human%20rectal%20cancer&rft.jtitle=Nature%20medicine&rft.au=Willett,%20Christopher%20G&rft.date=2004-06-01&rft.volume=10&rft.issue=6&rft.spage=649&rft.epage=649&rft.pages=649-649&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/nm0604-649c&rft_dat=%3Cspringer%3E10_1038_nm0604_649c%3C/springer%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true